Publicacións nas que colabora con Ricardo Blanco Alonso (18)

2023

  1. Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review

    RMD open, Vol. 9, Núm. 1

2021

  1. Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients

    Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 2, pp. 395-403

  2. Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes

    Clinical and experimental rheumatology, Vol. 39, Núm. 5, pp. 37-42

  3. Treatment with tofacitinib in refractory psoriatic arthritis: A national multicenter study of the first 87 patients in clinical practice

    Journal of Rheumatology, Vol. 48, Núm. 10, pp. 1552-1558

2020

  1. Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis

    Journal of Rheumatology, Vol. 47, Núm. 9, pp. 1344-1353

  2. The number of traditional cardiovascular risk factors is independently correlated with disease activity in patients with psoriatic arthritis

    Medicina (Lithuania), Vol. 56, Núm. 8, pp. 1-9

2019

  1. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

    American Journal of Ophthalmology, Vol. 200, pp. 85-94

  2. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

    Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 1, pp. 126-135

2018

  1. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients

    Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 1, pp. 22-27

  2. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: Multicentre retrospective study

    Rheumatology (United Kingdom), Vol. 57, Núm. 5, pp. 856-864

  3. Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review

    Clinical and experimental rheumatology, Vol. 36, Núm. 4, pp. 652-657

2017

  1. Anti–Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis–Associated Uveitis Refractory to Anti–Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients

    Arthritis and Rheumatology, Vol. 69, Núm. 3, pp. 668-675

2016

  1. Relapses in patients with Henoch-Schönlein purpura: Analysis of 417 patients from a single center

    Medicine (United States), Vol. 95, Núm. 28

  2. The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: Results of a multicentre open-label study

    Clinical and Experimental Rheumatology, Vol. 34, pp. 34-40

2015

  1. Efficacy of anakinra in refractory adult-onset still's disease multicenter study of 41 patients and literature review

    Medicine (United States), Vol. 94, Núm. 39, pp. e1554

2014

  1. Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 32, Núm. 5, pp. 640-646

  2. Patients with ankylosing spondylitis and low disease activity because of anti-TNF-Alpha therapy have higher TRAIL levels than controls: A potential compensatory effect

    Mediators of Inflammation, Vol. 2014

  3. Tocilizumab in refractory aortitis: A study on 16 patients and literature review

    Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82